2 research outputs found
<i>trans</i>-Thionate Derivatives of Pt(II) and Pd(II) with Water-Soluble Phosphane PTA and DAPTA Ligands: Antiproliferative Activity against Human Ovarian Cancer Cell Lines
No full textA series
of PTA and DAPTA platinum(II) and palladium(II) thionate
complexes of the type <i>trans</i>-[M(SN)<sub>2</sub>P<sub>2</sub>] were prepared from the reaction of <i>cis</i>-[MCl<sub>2</sub>P<sub>2</sub>] [M = Pt, Pd; P = PTA (1,3,5-triaza-7-phosphaadamantane),
DAPTA (3,7-diacetyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane)] with
the <i>in situ</i> generated sodium salts of the heterocyclic
thiones <i>S</i>-<i>m</i>-methylpyrimidine-2-thione, <i>S</i>-4,6-dimethylpyrimidine-2-thione, <i>S</i>-4,6-dihydroxypyrimidine-2-thione,
benzothiazole-2-thione, benzoxazole-2-thione, <i>S</i>-1,3,4,-thiadiazole-2-thione, <i>S</i>-4,5-<i>H</i>-thiazolan-2-thione, and <i>S</i>-pyrimidine-4(1<i>H</i>)-one-2-thione. The X-ray
structures of six of the compounds confirm the <i>trans</i> disposition and, only in the case of [Pd<sub>2</sub>Cl<sub>2</sub>(<i>S</i>-pyrimidine-4(1<i>H</i>)-one-2-thionate)<sub>2</sub>(PTA)<sub>2</sub>], a dinuclear structure with a Pd–Pd
distance of 3.0265(14)Å was observed. <i>In vitro</i> cytotoxicities against human ovarian cancer cell lines A2780 and
A2780cisR were evaluated for ten complexes showing a high inhibition
of cellular growth with a comparable inhibitory potency (IC<sub>50</sub>) against A2780 cells to that of cisplatin. Notably, the compounds
also show significant (up to 7-fold higher) activity in cisplatin-resistant
A2780cisR cell lines
<i>trans</i>-Thionate Derivatives of Pt(II) and Pd(II) with Water-Soluble Phosphane PTA and DAPTA Ligands: Antiproliferative Activity against Human Ovarian Cancer Cell Lines
No full textA series
of PTA and DAPTA platinum(II) and palladium(II) thionate
complexes of the type <i>trans</i>-[M(SN)<sub>2</sub>P<sub>2</sub>] were prepared from the reaction of <i>cis</i>-[MCl<sub>2</sub>P<sub>2</sub>] [M = Pt, Pd; P = PTA (1,3,5-triaza-7-phosphaadamantane),
DAPTA (3,7-diacetyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane)] with
the <i>in situ</i> generated sodium salts of the heterocyclic
thiones <i>S</i>-<i>m</i>-methylpyrimidine-2-thione, <i>S</i>-4,6-dimethylpyrimidine-2-thione, <i>S</i>-4,6-dihydroxypyrimidine-2-thione,
benzothiazole-2-thione, benzoxazole-2-thione, <i>S</i>-1,3,4,-thiadiazole-2-thione, <i>S</i>-4,5-<i>H</i>-thiazolan-2-thione, and <i>S</i>-pyrimidine-4(1<i>H</i>)-one-2-thione. The X-ray
structures of six of the compounds confirm the <i>trans</i> disposition and, only in the case of [Pd<sub>2</sub>Cl<sub>2</sub>(<i>S</i>-pyrimidine-4(1<i>H</i>)-one-2-thionate)<sub>2</sub>(PTA)<sub>2</sub>], a dinuclear structure with a Pd–Pd
distance of 3.0265(14)Å was observed. <i>In vitro</i> cytotoxicities against human ovarian cancer cell lines A2780 and
A2780cisR were evaluated for ten complexes showing a high inhibition
of cellular growth with a comparable inhibitory potency (IC<sub>50</sub>) against A2780 cells to that of cisplatin. Notably, the compounds
also show significant (up to 7-fold higher) activity in cisplatin-resistant
A2780cisR cell lines
